Anna Zorzet
- Molecular Biology
- Molecular Medicine top 2%
- Applied Microbiology and Biotechnology top 1%
- Genetics
- Infectious Diseases
- Co-authors
- Otto CarsJasper LittmannDan I. AnderssonUlf HammerlingAnnika I. NilssonDaniel Soeria‐AtmadjaMats G. GustafssonOtto G. Berg
- Topics
- Antibiotic Use and Resistance (8 papers)Antibiotic Resistance in Bacteria (5 papers)Peptidase Inhibition and Analysis (4 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Anna Zorzet
20 papers receiving 895 citations
Peers
Comparison fields: 5 of 131
- Molecular Biology 313
- Molecular Medicine 227
- Applied Microbiology and Biotechnology 193
- Genetics 105
- Infectious Diseases 100
Countries citing papers authored by Anna Zorzet
This map shows the geographic impact of Anna Zorzet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Zorzet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Zorzet more than expected).
Fields of papers citing papers by Anna Zorzet
This network shows the impact of papers produced by Anna Zorzet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Zorzet. The network helps show where Anna Zorzet may publish in the future.
Co-authorship network of co-authors of Anna Zorzet
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Zorzet. A scholar is included among the top collaborators of Anna Zorzet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Zorzet. Anna Zorzet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 50 | |
| 3 | Target Product Profile for a Diagnostic Assay to Differentiate Between Bacterial and Non-Bacterial Infections to Guide Antimicrobials Use in Resource-Limited Settings: An Expert Consensus | 1 |
| 4 | 49 | |
| 5 | 62 | |
| 6 | International Cooperation to Improve Access to and Sustain Effectiveness of Antimicrobials | 0 |
| 7 | 267 | |
| 8 | Global Importance of Antibiotics and Consequences of Antibiotic Overuse | 1 |
| 9 | Effective international collaboration to improve access to and sustain effectiveness of antimicrobials | 1 |
| 10 | An International Legal Framework to Address Antimicrobial Resistance | 5 |
| 11 | 19 | |
| 12 | 60 | |
| 13 | 11 | |
| 14 | 31 | |
| 15 | 21 | |
| 16 | 24 | |
| 17 | 105 | |
| 18 | 37 | |
| 19 | 57 | |
| 20 | 22 |
About Anna Zorzet
Anna Zorzet is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Immunology and Allergy, having authored 21 papers that have together received 916 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (193 citations), Molecular Medicine (227 citations) and Clinical Biochemistry (80 citations). Anna Zorzet has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Otto Cars, Jasper Littmann, Dan I. Andersson, Ulf Hammerling, Annika I. Nilsson, Daniel Soeria‐Atmadja, Mats G. Gustafsson, Otto G. Berg, Sabina Dahlström and Mats Gustafsson. Their work appears in journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.